Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Biome Grow Inc. is a Canadian cannabis company formerly focused on cultivating, processing, and distributing cannabis products for both medical and adult-use markets in Canada. The company operated primarily through a collection of provincially focused cannabis subsidiaries and production assets, with activities spanning cannabis cultivation, extraction, product development, and retail distribution partnerships. Public disclosures and market filings indicate that Biome Grow positioned itself as a regional cannabis operator emphasizing Atlantic Canada and underserved provincial markets during the early expansion phase of the Canadian legal cannabis industry.
The company’s historical business model centered on licensed cannabis production and sales through subsidiaries including Highland Grow Inc., The Back Home Medical Cannabis Corporation, and Great Lake Cannabis Company Inc. Revenue drivers historically included dried cannabis flower, cannabis derivative products, and supply arrangements with provincial distributors. Biome Grow evolved through acquisitions, licensing activity, and strategic investments after Canada legalized adult-use cannabis in 2018. However, publicly available filings and market disclosures indicate that the company experienced operational and financial challenges in subsequent years, including restructuring efforts and reduced operational activity. Data regarding current large-scale commercial operations is inconclusive based on available public sources.
Business Operations
Biome Grow historically organized its operations through cannabis cultivation and processing subsidiaries located across multiple Canadian provinces. Its operations included indoor and greenhouse cultivation facilities, cannabis genetics development, extraction capabilities, and product commercialization activities. The company generated revenue primarily through wholesale and retail cannabis sales into provincially regulated distribution systems. Public filings also referenced medical cannabis channels and provincial supply agreements as part of its operational strategy.
The company maintained operations and investments primarily within Canada, with a concentration in Nova Scotia, New Brunswick, and Ontario. Subsidiaries such as Highland Grow Inc. and The Back Home Medical Cannabis Corporation held cannabis licenses under Health Canada’s regulatory framework. Biome Grow also pursued strategic relationships with local operators and provincial stakeholders to expand distribution reach. Available filings indicate the company sought to differentiate itself through regional production capacity and local market positioning rather than through large-scale national dominance. Current operational scale and active production capacity cannot be fully verified from recent public disclosures.
Strategic Position & Investments
Biome Grow’s strategic direction historically focused on establishing a diversified portfolio of cannabis production assets across multiple Canadian provinces while leveraging local branding and regional market access. The company pursued growth through acquisitions, licensing activity, and investment in cultivation infrastructure during the rapid expansion phase of the Canadian cannabis industry. Notable transactions included involvement with Highland Grow Inc. and other cannabis operating entities intended to broaden production capacity and product offerings.
The company also explored cannabis derivative products and extraction opportunities as the Canadian market evolved beyond dried flower products. Public disclosures and financial filings indicate that Biome Grow invested in cultivation technology, facility development, and compliance infrastructure to support licensed cannabis operations. However, subsequent filings and market data suggest that the company faced liquidity constraints and operational restructuring pressures amid broader industry oversupply and pricing compression in Canada. Data concerning significant recent acquisitions, emerging technology investments, or active expansion initiatives is inconclusive based on available public sources.
Geographic Footprint
Biome Grow’s operations were concentrated in Canada, with a particular emphasis on the Atlantic Canada region. The company maintained headquarters operations in Nova Scotia and developed cultivation and processing assets in provinces including Nova Scotia, New Brunswick, and Ontario. Its market strategy focused on serving provincial cannabis distribution systems and establishing a regional presence within Canada’s regulated cannabis framework.
Unlike larger multinational cannabis operators, Biome Grow’s footprint was primarily domestic rather than global. Public records do not indicate a substantial international operational presence or major overseas investments. The company’s influence was therefore tied mainly to Canadian provincial cannabis markets and regional production initiatives. Data regarding any current international commercial activity is inconclusive based on available public sources.
Leadership & Governance
Biome Grow was founded and developed during the expansion phase of Canada’s legal cannabis sector, with leadership emphasizing regional market participation and strategic cultivation asset development. Public company disclosures historically described a strategy centered on disciplined provincial expansion, licensed production growth, and participation in Canada’s regulated cannabis ecosystem. Governance and executive leadership changed over time as the company underwent operational and financial restructuring.
Key executives and leadership figures identified in public filings and historical disclosures include:
- Khurram Malik – Chief Executive Officer
- Peter McNab – Chief Financial Officer
- David Chiasson – President of The Back Home Medical Cannabis Corporation
- Terrance Ryan – Executive associated with regional cannabis operations and subsidiary development
Recent executive and governance information may not be consistently updated across public market databases and company disclosures. Data inconclusive based on available public sources.